## Abstract Colorectal cancer screening is a high public health priority in all industrialized countries. However, the low sensitivity of the common guaiac screening test (HemoccultII) makes practitioners and public health decision makers reluctant to set up a national screening program. In recent
Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study
β Scribed by Hiroshi Saito; Yasushi Soma; Junichi Koeda; Toyohito Wada; Hitoshi Kawaguchi; Tomotaka Sobue; Tadashi Aisawa; Yutaka Yoshida
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 644 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Immunochemical fecal occult blood test (FIT) is a new colorectal cancer (CRC) screening method already recommended by the American screening guidelines. We aimed to test the feasibility of FIT as compared to guaiac fecal occult blood test (GβFOBT) in a large urban population of Tel Aviv
## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2005) 115(3) 493β496 DOI: 10.1002/ijc.20921
## Abstract The purpose of the study is to evaluate a new immunochemical fecal occult blood test method (Hemosure IFOBT), and compare it to the Guaiacβbased chemical method (CFOBT) for colorectal cancer detection. A hypothetical sequential method (SFOBT), in which IFOBT was used only as a confirmat